Characterization bacterial metabolites and peripheral immune cell populations in stable and progressive Alzheimer’s disease
Ethan B Loew, Matthew Tracy, Cynthia Jo, Beth McCormick, John P Haran · 2025
Read Characterization bacterial metabolites and peripheral immune cell populations in stable and progressive Alzheimer’s disease by Ethan B Loew, Matthew Tracy, Cynthia Jo, Beth McCormick, John P Haran (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710524.txt.
Description
Ethan Loew and co-authors compare gut chemistry and immune cells in Alzheimer's patients who decline fast versus those who stay stable, in a 2025 study. Alzheimer's always brings memory loss eventually, but its pace varies widely between people. Beyond the brain plaques and tangles, the body's wider immune system also drifts with the disease, losing fresh T cells and gaining worn ones.
The team profiled stool chemicals in thirty-five patients and thirty-five matched healthy controls using untargeted screening. One sulfur compound already stood out as elevated in patients. Ongoing work tracks blood immune cells and gut microbes over time in the same people. If gut or immune signatures predict who declines quickly, doctors could spot fast progressors early and perhaps intervene through the gut-immune route.
Catalog record
| CREATOR | Ethan B Loew, Matthew Tracy, Cynthia Jo, Beth McCormick, John P Haran |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |